Navigation Links
US Patent Office Rejects 95% of Verathon Claims in Patent Case With Aircraft Medical

EDINBURGH, Scotland, March 26 /PRNewswire/ -- On March 23, 2009 the United States Patent and Trademark Office ("USPTO") issued a Non-Final Action Closing Prosecution in the ongoing re-examination of Verathon, Inc.'s United States Patent Number 6,543,447. Aircraft Medical, Ltd. filed the request for the re-examination of this patent in 2006 following litigation (currently on hold) that Verathon initiated against Aircraft.

The new Action from the USPTO has rejected 393 claims that Verathon introduced during the re-examination procedure on grounds that they had impermissibly enlarged the scope of the patent. The remaining 19 claims that have been characterized as "patentable" have been substantially limited in scope compared to the original claims. This is not a final decision and Aircraft believes that the decision to uphold these limited remaining claims will be overturned on appeal.

Aircraft believes that this severe limiting of the claims represents a significant setback for Verathon and that the USPTO's characterization of even the remaining claims as "patentable" will be reversed in further proceedings. Aircraft maintains its position that none of its products fall within either the original or amended claims of Verathon's US Patent Number 6,543,447.


Aircraft Medical is the manufacturer of the McGrath(R) Series 5, the world's first fully portable video laryngoscope. Its compactness, and a cable free design, means the life saving benefits of video laryngoscope technology can fit in the pocket of a paramedic or mobile user. As a result, it is immediately available for use in potentially life threatening cases. The McGrath(R) Series 5 is leading the growth of the portable video laryngoscope market with distribution in North America, Europe and Australasia. Matt McGrath, Aircraft Medical's CEO, was last year named "Young Scot of the Year" by the Institute of Contemporary Scotland in recognition of the invention of McGrath(R) Series 5 and its advancement of healthcare and subsequent international success.

    Financial Dynamics
    Jonathan Birt: +44(0)207-269-7205
    John Dineen: +44(0)207-269-7205

SOURCE Aircraft Medical Limited
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
2. VisEn Medical Files Action to Invalidate New Caliper Life Sciences Patent
3. Pressure BioSciences, Inc. Issued First Patent in Canada
4. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
5. CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent
6. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
7. Weil Gotshal Wins Major Victory for Applera; Secures Summary Judgment Invalidating Three Patents
8. Angiotech receives favourable patent decision from New Zealands Intellectual Property Office
9. Angiotech reaches agreement with Johnson & Johnson to settle outstanding patent litigation
10. Warner Chilcott Announces New Information in USPTO Reexamination of Taclonex Patent
11. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
Post Your Comments:
(Date:11/25/2015)... HOLLISTON, Mass. , Nov. 25, 2015 /PRNewswire/ ... ), a biotechnology company developing bioengineered organ implants for ... will present at the LD Micro "Main Event" ... p.m. PT. The presentation will be webcast live and ... will also be available at the conference for one-on-one ...
(Date:11/25/2015)... 25, 2015 The Global ... a professional and in-depth study on the current ... (Logo: ) , The ... including definitions, classifications, applications and industry chain structure. ... international markets including development trends, competitive landscape analysis, ...
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... Nov. 24, 2015  Clintrax Global, Inc., a worldwide provider of ... , today announced that the company has set a new quarterly ... quarter on quarter growth posted for Q3 of 2014 to Q3 ... Mexico , with the establishment of an ... --> United Kingdom and ...
Breaking Biology Technology:
(Date:11/16/2015)... Nov 16, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced expansion of its TDDI product ... touch controller and display driver integration (TDDI) solutions ... These new TDDI products add to the previously-announced ... TD4302 (WQHD resolution), and TD4322 (FHD resolution) solutions. ...
(Date:11/10/2015)...  In this report, the biomarkers market ... type, application, disease indication, and geography. The ... consumables, services, software. The type segments included ... biomarkers, and validation biomarkers. The applications segments ... drug discovery and development, personalized medicine, disease ...
(Date:11/2/2015)...  SRI International has been awarded a contract of ... to the National Cancer Institute (NCI) PREVENT Cancer Program ... modern testing and support facilities, and analytical instrumentation to ... studies to evaluate potential cancer prevention drugs. ... Drug Development Program is an NCI-supported pipeline to bring ...
Breaking Biology News(10 mins):